Lizhi Lin

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Disease markers

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofen Zhou, Lizhi Lin, Yufeng Qi, Min Xu, Qiding Xu, Yinghao Wang, Jin-Miao Qu
SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis. Disease markers 2022 (2022)
Lizhi Lin, Jia-Liang Wen, Bangyi Lin, Adheesh Bhandari, Danni Zheng, Lingguo Kong, Yinghao Wang, Ouchen Wang, Yizuo Chen
Immortalization up-regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer. Journal of cellular and molecular medicine 24 (23) (2020)